BiotechTube
Home/Orbits Oncology/Maxim Le Compte
ML

Maxim Le Compte

Application Specialist

Orbits Oncology

Therapeutic Areas

Oncology

Orbits Oncology Pipeline

DrugIndicationPhase
Organoid Analysis PlatformOncology (Pancreatic Cancer validated)Development/Validation

Leadership Team at Orbits Oncology

AL
Abraham Lin
CEO
RS
Rebecca Stone
CTO
TG
Tyler Gilcrest
COO
CD
Christophe Deben
CSO
View full Orbits Oncology profile